A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial.

El-Haggar SM, Hegazy SK, Abd-Elsalam SM, Elkaeed EB, Al-Karmalawy AA, Bahaa MM.

Open source

DOI
10.2147/jir.s346608
Published
2022-02-19
Container
J Inflamm Res
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/jir.s346608,
  title = {A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial.},
  author = {El-Haggar SM and  Hegazy SK and  Abd-Elsalam SM and  Elkaeed EB and  Al-Karmalawy AA and  Bahaa MM.},
  year = {2022},
  journal = {J Inflamm Res},
  doi = {10.2147/jir.s346608},
  url = {https://doi.org/10.2147/jir.s346608}
}

RIS

TY  - JOUR
TI  - A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial.
AU  - El-Haggar SM
AU  -  Hegazy SK
AU  -  Abd-Elsalam SM
AU  -  Elkaeed EB
AU  -  Al-Karmalawy AA
AU  -  Bahaa MM.
PY  - 2022
JO  - J Inflamm Res
DO  - 10.2147/jir.s346608
UR  - https://doi.org/10.2147/jir.s346608
ER  - 

APA

SM, E., SK, H., SM, A., EB, E., AA, A., & MM., B. (2022). A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial.. J Inflamm Res. https://doi.org/10.2147/jir.s346608

Source records